FDA Approves Auto-Injector for Migraine, Cluster Headache

MedPage Today) — The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday. The prefilled syringe formulation…

About Author

Erasmo Grisby

See author's posts

FDA Approves Auto-Injector for Migraine, Cluster Headache

About Author

Erasmo Grisby

FDA outlines stricter Covid vaccine booster approval standards for healthy people

This Workout Plan Uses Science to Build Next-Level Core Strength

Fall Covid vaccine rollout for healthy kids, adults is likely not going to happen – NBC News

FDA outlines stricter Covid vaccine booster approval standards for healthy people

This Workout Plan Uses Science to Build Next-Level Core Strength

Fall Covid vaccine rollout for healthy kids, adults is likely not going to happen – NBC News

I Let ChatGPT Plan My Meals for Two Weeks

Mitochondrial protein may improve selective liver cancer treatment

The 15 Best Protein Bars, Approved By Dietitians and Editor Tested

Vutrisiran Snags FDA Approval for TTR Amyloidosis Cardiomyopathy

Immune cell dysfunction in GI tract may lead to onset of inflammatory bowel disease

Ultrafine bubble showers may help suppress atopic dermatitis

Study reveals a key mechanism for controlling the activity of neuronal identity regulators

FDA outlines stricter Covid vaccine booster approval standards for healthy people

This Workout Plan Uses Science to Build Next-Level Core Strength

Fall Covid vaccine rollout for healthy kids, adults is likely not going to happen – NBC News

I Let ChatGPT Plan My Meals for Two Weeks

Mitochondrial protein may improve selective liver cancer treatment

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories